← Companies|Upstream Bio
UP

Upstream Bio

UPB·NASDAQWaltham MAFounded 202050 employees
Small CapbiotechPublicRespiratoryImmunology
Platform: TSLP mAb
Market Cap
$0.8B
All Drugs
2
Clinical Trials
4
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (UPB)
Loading UPB stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
DatolucimabUPB-1163Approved3PeptideEZH2MeniniRett
UPB-4925UPB-4925Phase 2/31ERTKRASG12DFGFRiOCDMM
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)
2025-01-20
Datolucimab Ph3 Readout
Rett
Past
2025-12-01
UPB-4925 BTD
OCD
Past
2028-12-11
Datolucimab Ph3 Readout
Rett
Ph3 Readout
2031-03-13
Datolucimab Ph3 Readout
Rett
Ph3 Readout
2031-11-08
UPB-4925 Ph3 Readout
MM
Ph3 Readout